Skip to main content
. Author manuscript; available in PMC: 2013 Nov 3.
Published in final edited form as: Basic Clin Pharmacol Toxicol. 2013 May 20;113(2):92–102. doi: 10.1111/bcpt.12071

Figure 2. Glucuronide conjugation of bicalutamide enantiomers by microsomes from human liver, kidney and intestine.

Figure 2

Human liver, kidney or intestine microsomes (10 μg) were incubated in the presence of 100 μM of the racemic (R/S) mixture of bicalutamide (R/S, A and B), or of the pure (R)- (R, C) or (S)-enantiomers (S, D), and UDPGA (1 mM) for 18 hours at 37°C. The formation of (R)bicalutamide-glucuronide (R-G, A and C) and (S)bicalutamide-glucuronide (S-G, B and D) was analyzed by LC-MS/MS. Data represent the mean ± S.D. of two independent experiments performed in triplicate.

G: glucuronide.